Novartis Investigative Site

North Richland Hills, Texas 76180

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Relapsing Remitting Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early